Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Retained Earnings (2020 - 2026)

Maxcyte has reported Retained Earnings over the past 6 years, most recently at -$261.5 million for Q4 2025.

  • Quarterly Retained Earnings fell 20.58% to -$261.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$261.5 million through Dec 2025, down 20.58% year-over-year, with the annual reading at -$261.5 million for FY2025, 20.58% down from the prior year.
  • Retained Earnings was -$261.5 million for Q4 2025 at Maxcyte, down from -$251.9 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$106.7 million in Q2 2021 and troughed at -$261.5 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$170.5 million (2023), against an average of -$172.8 million.
  • Year-over-year, Retained Earnings dropped 18.63% in 2022 and then decreased 28.15% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$114.3 million in 2021, then fell by 20.62% to -$137.9 million in 2022, then decreased by 27.51% to -$175.8 million in 2023, then dropped by 23.35% to -$216.9 million in 2024, then fell by 20.58% to -$261.5 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Retained Earnings are -$261.5 million (Q4 2025), -$251.9 million (Q3 2025), and -$239.5 million (Q2 2025).